Lydian Capital

Gemina Capital Management is a financial management firm based in New York, NY, currently updating its online presence. The company is affiliated with ACI Capital, which has been in operation since 2014 and retains all rights related to its services. Focused on delivering tailored investment solutions, Gemina Capital Management aims to guide its clients through the complexities of the financial landscape. The firm prides itself on its commitment to excellence and client satisfaction within the competitive financial services industry. Generated from the website

Investors Alley Corp is a New York-based company that is dedicated to protecting the privacy of its customers. They collect limited personal information to enhance the user experience on their website and develop content tailored to users' interests. The company is committed to not sharing any personal information with third parties, unless required by law. With industry-standard security safeguards in place, Investors Alley Corp ensures the protection of personally identifiable information from loss, misuse, or unauthorized alteration. They offer users the ability to correct or update their information and provide options to unsubscribe from future mailings. The company also maintains public forums for users to engage in discussions, but advises caution when disclosing personal information in these areas.Generated from the website

Lancer Industries Inc., based in New York, NY, is a middle-market business builder focused on transforming promising companies into market leaders. With three decades of experience, the firm leverages its $8 billion in committed capital and a robust portfolio of 59 platform investments to drive growth in sectors such as healthcare, industrials, and business services. Known for its collaborative approach, Lancer Industries partners with businesses by providing not only capital investment but also essential operational strategy and market insights. Their commitment to long-term growth potential is evident in their extensive track record of 183 total acquisitions, reinforcing their role as a trusted ally in the bio-pharmaceutical industry and beyond. Generated from the website